Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions 
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers 
Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom 
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit 
Ford Issues Major Recall on Over 422,000 Vehicles Due to Windshield Wiper Defect 
UPS and Teamsters Reach Agreement to Limit Driver Severance Program 
TSMC Japan's Second Fab to Produce 3nm Chips by 2028 
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports 
First Western Ship Transits Strait of Hormuz Since Iran War Began 
Deere & Company Agrees to $99 Million Settlement Over Right-to-Repair Dispute 
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs 
LG Electronics Posts Record Q1 Revenue Amid Strong Demand and Cost Improvements 
SpaceX IPO: Retail Investors to Play Historic Role in Record-Breaking Public Offering 
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO 
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman 
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage 
 ANNOUNCES U.S. ORGANIC CERTIFICATION - EconoTimes)
Clearwater, FL, Oct. 03, 2016 --
Acacia Diversified Holdings, Inc. (OTCQB:ACCA) (the “Company”) today announced that its wholly-owned subsidiary, MariJ Pharmaceuticals, Inc. (“MariJ”), has received an Organic Certification for its proprietary CO2 mobile cannabis oil extraction process and handling.
OneCert, Inc. issued MariJ an Organic Certification under the U.S National Organic Program (7 CFR Part 205) effective September 28, 2016. MariJ will now be able to process directly for certified organic farms, and will be able to produce certified organic cannabis oils.
Rick Pertile, President and CEO of Acacia said: "We are very excited to have been granted a U.S. National Organic Certification. We believe we are the very first CO2 mobile extraction company that has received such a coveted certification.”
Forward-Looking Statements
Statements in this press release may be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "anticipate", "believe", "estimate", "expect", "intend" and similar expressions, as they relate to the Company or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the Company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this release. Information on the Acacia or MariJ Pharmaceuticals websites does not constitute a part of this release.
Mr. Richard K. Pertile, CEO MariJ Pharmaceuticals, Inc. Canna-Cures Research & Development Center, Inc. (Acacia Diversified Holdings, Inc. companies) 13575 58th Street North - #138 Clearwater, FL 33760 Email: [email protected] Internet: http://www.marijinc.com/ Office: (727) 678-4420 Fax: (877) 513-6295
